Here’s whether QIAGEN N.V. (QGEN) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.52% over 10 days); RSI 62 — healthy momentum range; 3-month momentum positive (+30.2%). Concerns: weak 1-year return of -12.3%. Currently 25.7% off its 52-week high. Score: +5/7.
QGEN is in a confirmed uptrend, trading above both its 50-day ($40.02) and 200-day ($42.84) moving averages. An RSI of 62.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -12.3% compares to +20.4% for SPY (trailed the market by 32.6%). The current 25.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $8,772 today
vs. S&P 500 (SPY) — same period trailed market by 32.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($42.84)
✓Above 50-day MA ($40.02)
✓RSI(14) neutral zone (30–70) — currently 62.0
✗Positive return (-12.3%)
!Within 10% of period high (−25.7%)
Period Range $42.95
$32.53$57.82
RSI (14) 62.0
0 · OversoldOverbought · 100
Key Metrics
Price$42.95
Period Return-12.3%
Period High$57.82
Period Low$32.53
Drawdown−25.7%
MA-50$40.02
MA-200$42.84
RSI (14)62.0
Avg Volume (30d)3.0M
vs. SPYtrailed by 32.6%
Return Rank#802 of 1252
Trend Signals
Price is above the 200-day moving average ($42.84)